Skip to Main Content
An official website of the United States government

Approved Projects

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Filter results of approved projects table below

Approved Projects
Name Principal Investigator Institution Study Date Approved Project ID
Early Risk Prediction of Ovarian Cancer Using Multimodal Clinical and Biomarker Data Vanshika Sharma Chandigarh University PLCO Feb 23, 2026 PLCO-2020
A Risk-Stratified Decision Support Framework for Prostate Cancer Screening Using the PLCO Trial Dataset Priya Dubey Tokyo International University PLCO Feb 23, 2026 PLCO-2014
Validation of CA-125 Kinetic Models for Early Ovarian Cancer Detection Using Machine Learning Fahad Kiani CrisPRO.ai PLCO Feb 23, 2026 PLCO-2010
Timing Patterns of Coffee, Dairy, and Protein Intake and Their Measurement Reliability Using Repeated 24-Hour Dietary Recalls in the iDATA Study Qibin Qi Albert Einstein College of Medicine IDATA Feb 23, 2026 IDATA-98
Standardization of Imaging Interpretation for Early Lung Cancer Detection, Intelligent Learning Platforms, and Public Education Outreach Dr. Yeun-Chung Chang The Radiological Society of the Republic of China (RSROC) NLST Feb 20, 2026 NLST-1493
Plasma proteomics markers for risk prediction of incident lung cancer Charles Swanton Francis Crick Institute PLCO Feb 19, 2026 2025-0069
DNA methylation and dietary sodium intake Jeong Yun (John) Yang Columbia University Irving Medical Center PLCO Feb 17, 2026 PLCO-2023
Dietary Advanced Glycation End-Products (dAGE) and Prostate Cancer Susan Steck University of South Carolina PLCO Feb 13, 2026 PLCO-2021
Computational Prediction of Gene Expression and Clinical Outcomes from Digital Pathology Images Mingyao Li University of Pennsylvania PLCO Feb 13, 2026 PLCOI-2022
Chrono-Cuisine: Investigating Meal Timing Patterns and Cancer Susceptibility Mary Playdon The University of Utah IDATA Feb 6, 2026 IDATA-97
Validation of a Morphology-Based Risk Taxonomy (Favorable, Borderline, Unfavorable Histology) for Prostate Cancer Using PLCO Trial Data Enrico Munari University Hospital Trust Verona PLCO Feb 4, 2026 PLCOI-2019
Bone Marrow Extracellular Matrix Gene Expression Analysis for Cancer Prognosis and Bone Metastasis Prediction: An 82-Gene Panel Study Using PLCO Trial Data Shelly Peyton Trustees of Tufts College PLCO Feb 4, 2026 PLCO-2011
Causal predictive modeling of survival of Breast cancer: A comparative study with machine learning, traditional survival modeling methods, and causal survival models Hansapani Rodrigo University of Texas Rio Grande Valley PLCO Feb 4, 2026 PLCO-2015
Calibration of a microsimulation model of lung cancer natural history in Australia Marianne Weber The University of Sydney NLST Feb 4, 2026 NLST-1495
Epstein-Barr virus-associated neo-antigens in advanced prostate cancer Denong Wang SRI International PLCO Feb 2, 2026 2025-0062
Evaluating lung cancer screening by competing mortality Rebecca Landy American Cancer Society NLST Jan 29, 2026 NLST-1496
Predicting eligibility for lung cancer screening Robert Volk University of Texas MD Anderson Cancer Center PLCO Jan 26, 2026 PLCO-2018
Impact of a secondary biomarker on time-to-event risk prediction of prostate cancer mortality in a screening cohort Kristian Stensland The University of Michigan PLCO Jan 26, 2026 PLCO-2012
Identifying histological features of lung cancer using deep learning Jennifer Beane Trustees of Boston University NLST Jan 26, 2026 NLST-1494
Prevalence and Prognostic Significance of Dendriform Pulmonary Ossification in the National Lung Screening Trial Kyung Hee Lee University of Pittsburgh NLST Jan 26, 2026 NLST-1491